drugset / Trial / NCT02759991

Effectiveness Trial to Evaluate Protection of Pregnant Women by Hepatitis E Vaccine in Bangladesh.

NCT02759991

RandomizedParallel-groupQuadruple-blindPrevention

Summary

The aim of the study is to determine the effectiveness of hepatitis E virus vaccine given in women of child bearing age in preventing HEV disease during pregnancy among women in rural Bangladesh.

Timeline

Start
2017-10-02
Primary completion
2019-09-30
Completion
2019-09-30

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hecolin® Vaccine 0.6 ml Intramuscular
Comparator Hepa-B Vaccine 1 ml Intramuscular